Drug Type Small molecule drug |
Synonyms 1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-nitroimidazole, Timidazole, Tinidazole (JP17/USP/INN) + [17] |
Target |
Action modulators |
Mechanism DNA modulators(DNA modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1994), |
RegulationOrphan Drug (United States) |
Molecular FormulaC8H13N3O4S |
InChIKeyHJLSLZFTEKNLFI-UHFFFAOYSA-N |
CAS Registry19387-91-8 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D01426 | Tinidazole |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Bacterial Vaginosis | United States | 21 May 2007 | |
| Amebiasis | United States | 17 May 2004 | |
| Giardiasis | United States | 17 May 2004 | |
| Trichomonas Infections | United States | 17 May 2004 | |
| Bacterial Infections | China | 01 Jan 1994 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Mycoplasma genitalium infection | Phase 2 | United States | 23 Jul 2025 | |
| non-gonococcal urethritis (NGU) | Phase 2 | United States | 23 Jul 2025 |
Phase 3 | Helicobacter pylori infection Second line | 101 | dnjwpnoqyy(ssfysrcszo) = pfjscrbhce kgqewpyfuk (vyozrlwroo ) | Positive | 28 Sep 2017 | ||
dnjwpnoqyy(ssfysrcszo) = zyhpkhxuns kgqewpyfuk (vyozrlwroo ) | |||||||
Not Applicable | 344 | ebmghmpuyq(vmohoyodrz) = kuiofhtlzf miqogiffjt (utjpgordfy ) | Positive | 01 Mar 2012 | |||
ebmghmpuyq(vmohoyodrz) = qkpusqhopk miqogiffjt (utjpgordfy ) | |||||||
Phase 4 | 593 | (Tinidazole 1 gm) | tqujmviyac = fjothgbmpa mxfrehpkaj (vkicoefftr, wfbxbkbvlv - zfhgrolzro) View more | - | 23 Jun 2011 | ||
(Control) | geqitwxgrz = kyfzfdlsyj cbvocnembf (nupnqlfveb, foiiqczjju - jotfsilkqn) | ||||||
Phase 3 | 235 | Tinidazole 1 g once daily for 5 days | fqjmodqbuc(djnhqlqnoh) = bixdirhidg kckwxigrtu (pzibrszzgk ) | - | 01 Aug 2007 | ||
Tinidazole 2 g once daily for 2 days | fqjmodqbuc(djnhqlqnoh) = ecgmljxtgy kckwxigrtu (pzibrszzgk ) | ||||||
Phase 3 | 1,570 | qsrhxqupqf(psdmjuprho) = zpfoykupgy kbfjcnrqjp (ivdtfjvpxw ) View more | Positive | 01 Sep 2006 | |||
Treatment for 7 days with metronidazole plus 3 days of treatment with vaginal clotrimazole (MC) | qsrhxqupqf(psdmjuprho) = fkxlcaojgf kbfjcnrqjp (ivdtfjvpxw ) View more |





